NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 358 filers reported holding NOVOCURE LTD in Q4 2020. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $211,573 | -17.9% | 3,518 | +0.1% | 0.03% | -22.2% |
| Q4 2022 | $257,679 | -3.5% | 3,513 | -0.2% | 0.04% | -16.3% |
| Q3 2022 | $267,000 | +9.4% | 3,520 | +0.1% | 0.04% | +16.2% |
| Q2 2022 | $244,000 | -16.2% | 3,516 | +0.2% | 0.04% | -5.1% |
| Q1 2022 | $291,000 | +10.6% | 3,509 | 0.0% | 0.04% | +11.4% |
| Q4 2021 | $263,000 | -36.2% | 3,509 | +0.1% | 0.04% | -37.5% |
| Q3 2021 | $412,000 | -47.0% | 3,507 | 0.0% | 0.06% | -47.7% |
| Q2 2021 | $778,000 | +67.7% | 3,507 | 0.0% | 0.11% | +55.1% |
| Q1 2021 | $464,000 | -23.6% | 3,507 | 0.0% | 0.07% | -34.3% |
| Q4 2020 | $607,000 | – | 3,507 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 470,884 | $27,923,000 | 10.09% |
| Darsana Capital Partners LP | 1,700,000 | $100,810,000 | 5.98% |
| HARTLINE INVESTMENT CORP/ | 336,617 | $19,961,000 | 4.18% |
| Rhenman & Partners Asset Management AB | 375,000 | $22,238,000 | 2.40% |
| MORGAN JESS S & CO INC | 35,942 | $2,131,000 | 2.31% |
| Soleus Capital Management, L.P. | 56,397 | $3,344,000 | 1.91% |
| Bullseye Asset Management LLC | 45,161 | $2,678,000 | 1.43% |
| Taylor Frigon Capital Management LLC | 46,304 | $2,746,000 | 1.36% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $593,000 | 1.09% |
| Redwood Investments, LLC | 192,986 | $11,444,000 | 1.01% |